{
    "nct_id": "NCT04037527",
    "official_title": "Phase I Trial Study of Gemcitabine and Docetaxel With Radiation in Adult Patients With High Grade and Greater Than 5 cm Soft Tissue Sarcoma of the Extremities",
    "inclusion_criteria": "* Patients must have a histologically or cytologically confirmed Grade II or III soft tissue sarcoma that is considered to be resectable and are candidates for pre-op radiation.\n* Age greater than or equal to 18 years. No children will be enrolled on this protocol.\n* Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2.\n* Women of child-bearing potential and men must agree to use adequate contraception (hormonal or double-barrier method of birth control; abstinence) prior to study entry and for the duration of study participation. Should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately.\n* Ability to understand and the willingness to sign a written informed consent document.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients taking concurrent hormonal therapy, biologic or other chemotherapy are excluded except women on hormonal contraceptives.\n* Patients taking an investigational agent are excluded.\n* Pregnant and nursing women are excluded.\n* Patients who require amputation for local control.\n* Patients who underwent unplanned excision or other previous surgery involving the affected extremity.\n* Patients with sarcoma subtypes for which established chemotherapeutic regimens exist.\n* History of radiation to the limb.",
    "miscellaneous_criteria": ""
}